16 September 2026 note archive · Item
Tandem t:slim X2 (Control-IQ+): review notes
These archived notes document the scope reviewed on 16 September, including source-access limits. They do not cover later changes or newly added records. They are not independent clinical certification or a guarantee that every claim was verified.
Read the item evidence page →Thriving evidence review — 16 September 2026
Record: Tandem Control-IQ+
Scope and findings:
- Read current manufacturer labeling: T1D2+, T2D18+, at least5U/day and 9kg; adaptive basal and up-to-hourly automatic correction boluses. Age indication does not override sensor/pump compatibility. Historical all-cohort performance not independently reanalysed.
Primary sources checked:
Limits: The review is restricted to the scopes above. Historical efficacy estimates, editorial scoring and country-specific access were not fully reverified unless expressly stated. A manufacturer or conference report retains that evidence level.